It's nearly party time ?
Time to bring out some balloons
A considerable difference in the Balloons for the Psychedelics Trial with a massive up ramping for GAD.
I think this has gone a little under the radar in the discussion here so far.
"The Company is now in the process of co-ordinating two clinical trials as part of the clinical development program aimed at achieving FDA approval for Psi-GAD therapy "
The latest Activities report noted that they have decided to split the 1st GAD Trial into two phases
1st Part will be 30 of the total 72 patients
2nd Part will be the remaining 42 of the 72 patients
After the 1st phase is completed it will enable a review of the data to inform the 2nd Phase of the Trial and or
The 2nd Phase 2b Trial which Incannex are actively planning.
"Preparations for this larger, pivotal, multi-site phase 2b clinical trial are continuing"
We saw how how the BOD added a W.A. Trial to the Sleep Apnoea Trial in order to be compliant with the FDA multi-site evidence gathering requirement, seems they are preparing for the same with the GAD Trial.
The additional LARGER, MULTI-SITE Phase 2 Trial has been added.
More news flow for the North American Market folks!
CLICK THIS UPDATED IMAGE FOR A LARGER VIEW
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-6757
-
- There are more pages in this discussion • 13,142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online